CEO Jason Hollar Sells $29.4M in Cardinal Health Shares
CAH sits 60% above its 52-week low of $145.87.
Summary
Cardinal Health CEO Jason Hollar sold $29.4 million in shares, cutting his direct stake by nearly 30% amid a broader insider selling trend.
Key Events · Ownership and Investor Activity · CAH
-
CEO Sells $29.4M in Shares
Jason Hollar sold 124,529 shares at prices ranging from $233.22 to $237.88, totaling $29,375,515.59.
-
Stake Reduced by Nearly 30%
The sale reduced Hollar's direct holdings from 418,254 to 293,725 shares, a 29.8% decrease.
-
Broader Insider Selling Trend
This follows a 90-day insider distribution pattern totaling $29.6M in net sales, including a $8.27M sale by segment CEO Stephen Mason disclosed the same day.
-
Post-Earnings Timing
The sale occurred one week after Cardinal Health reported Q4 FY26 EPS of $1.70 (up 70%) and raised FY27 guidance above consensus.
Analysis · CAH · Trade & Services
CEO Jason Hollar sold 124,529 shares for $29.4 million over two days, reducing his direct holdings by nearly 30%. This is the largest insider sale in the recent 90-day window and follows a broader distribution trend among Cardinal Health executives, including a $8.27M sale by segment CEO Stephen Mason disclosed the same day. While the dollar amount is modest relative to the company's $54.6B market cap, the CEO's decision to trim his stake by almost a third is a notable signal of insider sentiment, especially after a strong Q4 earnings report and a 70% EPS surge.
At the time of this filing, CAH was trading at $233.08 on NYSE in the Trade & Services sector, with a market capitalization of approximately $54.6B. The 52-week trading range was $145.87 to $258.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.